Model Development of Food and Drug Administration Performance Measurement through Integrating Pharmaceutical Good Governance and Resiliency in Pharmaceutical Sector approaches

Introduction: Organizational performance is a function of the principles that each organization has to observe in various circumstances, and it is also a function of managing uncertainties. This study was aimed to determine what dimensions should be considered to measure the performance of Iranian Food and Drug Administration (IFDA) the organization with the goal of establishing the principles of optimal governance as well as resilience to uncertainties. Moreover, the research was focused to develop an optimized model for improving IFDA governance. Methods: In the first phase of this study, through semi-structured interviews and using thematic analysis, the performance dimensions of IFDA were identified based on Pharmaceutical Good Governance and Resiliency in Pharmaceutical Sector approaches. In the second phase, the extracted dimensions were weighted by a Thurston questionnaire trough Delphi method in two rounds and the final model of organization performance measurement was depicted based on Interpretive Structural Modeling. Results and discussion: In the first step, after identifying the ten principles of good resilient governance (GRG), these dimensions were categorized into three levels, which transparency , quality and rule of law , and anti-corruption measures were the most important principles for IFDA. Secondly, based on the consensus, and in terms of hierarchy of implementation, GRG model is explained as Practicing governance based on the principles of Organizational reengineering, Transparency, Quality and rule of law, Responsiveness, Justice, Anti-corruption measures, Stakeholders participation, Effectiveness and efficiency, Resiliency, and ultimately Sustainability . Conclusion: By implementing GRG model, IFDA has been able, over successive periods, to assess the extent of its progress in establishing an optimal governance system and to measure its impact on IFDA inherent tasks. Furthermore, it facilitates the engagement of stakeholders in order to achieve the strategic goals of the pharmaceutical system and helps policy makers to break free from the recurring and foreseeable challenges.

کلیدواژه ها:

Good Governance ، Resiliency ، Good Resilient Governance ، Performance Measurement ، Food and Drug Administration